VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer. Clin Cancer Res. 2011 Jun 01; 17(11):3716-26.
View in:
PubMed
subject areas
Animals
Apoptosis
Bridged-Ring Compounds
Cell Line, Tumor
Cell Proliferation
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Gene Expression Regulation, Neoplastic
Humans
Inhibitor of Apoptosis Proteins
Mice
Mice, Nude
Ovarian Neoplasms
RNA Interference
RNA, Messenger
RNA, Small Interfering
Taxoids
authors with profiles
GABRIEL LOPEZ
ANIL K SOOD